Uploaded October 2026 | Updated November 2026, 1 day ago
As the inaugural webinar of the American Heart Association's IMPACT ATTR initiative, this webinar will explore opportunities to improve the diagnosis and care of patients with ATTR-CM through earlier recognition and broader awareness across care settings. Drawing on their expertise and experience in cardiac amyloidosis care, Dr. Janice Pieretti and Dr. Joshua Mitchell will share practical insights, real-world experiences, and examples of approaches being used to increase awareness, support earlier identification of ATTR-CM, and extend expertise beyond specialty centers and cardiology providers.
Key topics will include:
-- Overview of ATTR-CM presentation and diagnosis
-- Real-world experiences in early identification of ATTR-CM, from simple interventions to AI-enabled solutions
-- Strengths and limitations of EHR tools, including order sets and electronic alerts
-- Techniques to reduce referral times and overcome barriers to treatment
-- Approaches to outreach and collaboration across specialties and health care systems
-- Lessons learned from the BEACON initiative (Building Effective Amyloidosis Care Networks)
This event will include dedicated time for audience questions, giving participants the opportunity to ask Dr. Pieretti and Dr. Mitchell questions directly during a live Q&A session.
Chapters
0:00 Introduction and Attendee Instructions
04:19 Dr. Pieretti, MD “From Clinical Suspicion to Scalable Systems of Care”
20:21 Dr. Mitchell, MD, MSCI “Barriers We Can Name, and Implementation We Can Copy”
45:01 Q&A and Closing Statements
As the inaugural webinar of the American Heart Association's IMPACT ATTR initiative, this webinar will explore opportunities to improve the diagnosis and care of patients with ATTR-CM through earlier recognition and broader awareness across care settings. Drawing on their expertise and experience in cardiac amyloidosis care, Dr. Janice Pieretti and Dr. Joshua Mitchell will share practical insights, real-world experiences, and examples of approaches being used to increase awareness, support earlier identification of ATTR-CM, and extend expertise beyond specialty centers and cardiology providers.
Key topics will include:
-- Overview of ATTR-CM presentation and diagnosis
-- Real-world experiences in early identification of ATTR-CM, from simple interventions to AI-enabled solutions
-- Strengths and limitations of EHR tools, including order sets and electronic alerts
-- Techniques to reduce referral times and overcome barriers to treatment
-- Approaches to outreach and collaboration across specialties and health care systems
-- Lessons learned from the BEACON initiative (Building Effective Amyloidosis Care Networks)
This event will include dedicated time for audience questions, giving participants the opportunity to ask Dr. Pieretti and Dr. Mitchell questions directly during a live Q&A session.
Chapters
0:00 Introduction and Attendee Instructions
04:19 Dr. Pieretti, MD “From Clinical Suspicion to Scalable Systems of Care”
20:21 Dr. Mitchell, MD, MSCI “Barriers We Can Name, and Implementation We Can Copy”
45:01 Q&A and Closing Statements










